This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Heidelberg Pharma Research Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Barbara Korsak: Innovator in PSMA-Targeting Conjugates
Introduction
Barbara Korsak is a prominent inventor based in Ladenburg, Germany. She has made significant contributions to the field of pharmaceutical research, particularly in the development of targeted therapies. Her innovative work focuses on creating conjugates that can effectively target specific cancer markers.
Latest Patents
Barbara Korsak holds 1 patent for her invention titled "PSMA-targeting amanitin conjugates." This invention relates to a PSMA-targeting conjugate that comprises an amatoxin, a small molecule PSMA-targeting moiety, and optionally a linker that connects the amatoxin and the small molecule. Additionally, the invention includes a pharmaceutical composition that utilizes such a conjugate, showcasing her commitment to advancing cancer treatment options.
Career Highlights
Barbara is currently employed at Heidelberg Pharma Research GmbH, where she continues to push the boundaries of pharmaceutical innovation. Her work is characterized by a strong focus on developing targeted therapies that can improve patient outcomes in oncology.
Collaborations
Throughout her career, Barbara has collaborated with notable colleagues, including Francesca Gallo and Christoph Mueller. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Barbara Korsak is a trailblazer in the field of pharmaceutical research, with her work on PSMA-targeting conjugates paving the way for new cancer therapies. Her dedication to innovation and collaboration exemplifies the spirit of advancement in medical science.